Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00701_DB00864_nanopub.RAsaEFUOehqKC0KvhXrXyin5pgwYWOEPK6mQYTrpyYnsE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00701_DB00864 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00701_DB00864 label "DDI between Amprenavir and Tacrolimus - The protease inhibitor, Amprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Amprenavir therapy is initiated, discontinued or altered. [drugbank_resource:DB00701_DB00864]" assertion.
- drugbank_resource:DB00701_DB00864 identifier "drugbank_resource:DB00701_DB00864" assertion.
- drugbank_resource:DB00701_DB00864 title "DDI between Amprenavir and Tacrolimus - The protease inhibitor, Amprenavir, may increase the blood concentration of Tacrolimus. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Amprenavir therapy is initiated, discontinued or altered." assertion.
- drugbank:DB00864 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00701_DB00864 assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00701_DB00864 assertion.